Search

The UK government has announced it is investing £8.7 million in an Airbus-led project to develop simulation software for aircraft design.

The first programme in a multinational scheme to generate vaccines needed in the developing world by guaranteeing a market in advance of their development has got under way.

With £125 billion a year to throw around, shouldn't the UK government think "innovation" a bit more when it opens the public purse? NESTA thinks so.

You would think that the launch of Framework 7 would be an opportunity to publicise the virtues of science. On the other hand, if you’re the UK government, maybe not.

Innovation policy needs to be tailored to take account of complexity and prevent neighbouring regions competing for the same resources

We would like to bring you news of the UK launch of Framework Programme 7, but we can’t because the press was not invited to the event. Instead, here’s the media release.

New guidelines for scientists involved in human embryonic stem cell research call for special scrutiny of the work, and specify ethical standards.

Scientists in the two newest EU members may have more reason to cheer their accession than the farmers and labourers who were expected to benefit most.

A new report from the OECD makes uncomfortable reading for anyone in Switzerland involved in educational R&D.

Who cares about Brussels? Apparently scientists do, with over 200,000 application forms for its €4 billion fund already downloaded. What next? Commissioner Janez Potočnik wants an EU-wide debate.

Under pressure to demonstrate economic returns on research spending, the UK’s research councils are going to make academics think commercial and to cosy up to industry.

The Lisbon strategy aim of making Europe the leading knowledge-based economy remains a far-off aspiration. Now the UK wants a fresh approach to the single market to move things forward.

In the lean years since the post-genomics bust, venture funding has been hard to come by for Europe’s biotech start-ups. Now they have polished up their business models, and valuations are low, attracting investors back in.

Europe’s companies increasingly recognise that they need to switch from fierce protection to licensing widely to generate revenues.